What? It makes absolutely no difference as far as raising the dividend how mnay shares are oustanding. It's the same cash out the door. THey just doubled the viidend per shares to account for half the number of shares O/S and the stock price. Same yield, same cash out the door
They hoped to get it in December but they have also said repeatedlty at recent conferences that they have no control over the FDA. It could come today, it could come in June, or it might not come at all.
December 15, 2014
MiMedx raises FY15 revenue view to $190M from $175M, consensus $181.1M
MiMedx CEO Parker H. "Pete" Petit stated, "We are pleased to report our expectations for another year of impressive growth. We are raising our earlier forecast for 2015 revenue to range from $175M to $190M. The low end of our 2015 expectations represents approximately a 50% increase and the high end of our guidance represents approximately a 64% increase over our forecasted 2014 revenue. We are very pleased with our 12 consecutive quarters of meeting or exceeding our revenue forecasts, and we plan to continue to add additional quarters to that consecutive record next year." The company said it expects to finish 2014 with approximately 170 sales professionals in its direct sales force, and its 2015 forecast projects that number to grow to well over 200 by year-end 2015
Agree..should be next week. I am not counting on FDA which is too bad because what they decide of course would affect guidance. But, at least we know that without FDA decision, there is only upside to guidance since zero is in guidance
Yes, we have seen "rebecca" on the MDXG board over time. A complete dimwit and has suffered much pain on MDXG if it really has shorted it. Trust me, it has no fund as fund managers don't shop at Sears, a store for the foks struggling to make a living. Rebecca, you could have at least said you were shoppping at Nieman Marcus if you wanted to pretend to be someone of means, rather than Sears. Kind of a dead give away. It is akin to if you had said you went for a steak last night to Texas Road House or Lone Star or Ponderosa.
Oppenheimer conference tomorrow. A chance for some money managers not familiar with MDXG to hear the story
Bof A note today. MDT still has $8 billion left after use of bond sale for M&A
Following the debt financing of the COV deal earlier this week we are adjusting our model and FCF analysis. As our analysis in this note highlights, even with $37bln in debt at close MDT can hit its 2018 leverage targets in our view with little to no debt pay down given the 8% EBITDA growth we forecast, which leaves MDT with roughly $8bln in FCF to allocate to dividends, buybacks or M&A. With about $5bln of that FCF untrapped, we believe MDT has the flexibility to move to a 40-50% dividend payout ratio and deliver double digit total returns for years to come. MDT has had a strong run of late, but we see the potential for another 15% upside based on our view that an increasing dividend and consistent 7-10% EPS growth (MDT has not missed a quarter since the current CEO took over 3 years ago) can justify a 16x multiple on our 2016 estimate. With the financing terms now set, our fiscal 2016- 2018 cash EPS estimates move to $4.89, $5.46 and $5.97. Our CY2016 estimate is $5.27. We are raising our PO to $85.
On October 30 they gave preliminary guidance for 2015 of 175-185 million. They should have a better window in a couple of weeks but that will depend on what they are hearing from the FDA if anything as well as if they have a better feel for how Zimmer and MDT are going to ramp up. It would be nice to see them go up to 185-195 million but keep in mind, Petit likes to under promise and over deliver.
This company was terribly mismanaged in the past with in my opinion an incompetent CEO and a board to match. They now appear to have a competent CEO who now has to clean up the sins of what came before him. I think 2015 will be much better.
Potential catalyst in the next 2 weeks if MDXG is in a position to raise the preliminary 2015 guidance they gave last month. They said they will give detailed guidance mid December.
Imagine the stuff "it" will dream up when the stock is $15 and his shorts are squeezed to the point of getting a weddgie
Well, everything else he has claimed proved to be wrong so he has to reach for something that is even more moronic. He's desperate.
Hey Cez, I know your jjust a kid or a dimwit, or both, but have you ever heard of insurance? Every public company has it. Chubb a big provider. I do not believe there is liability here but even if there is, who cares? It's covered.
CEZ, That's because judges aren't very bright, like law professors. The old saying those that can, do, those that can't teach, or become judges. Most law professors have never been in a coourt room and don't know how things really happen and most judges have no business experience or financial acumen and don't understand that there is nothing peculiar about officers cashing in options as they vest, particularly when they are up 1000% on them and get replenished every year. maybe you think having your entire net worth tied up in your company stock is a good strategy..I don't know too many people who are that dumb, except for you.
Cez/candy, one would argue that he sold out of stupidity, not luck since anyone who sold the stock at $6 is of course wondering what in the world he was thinking with the stock almost doubling from there. Exactly why only dimwit investors like you attach any relevance to modest insider selling (yes I have done the same thing with my equity awards at the public companies I have been with) because often times, one's net worth becomes dominated by one's company stock, never advisable no matter how bullish you are on your company's prospects. the sales you pointed out were stock option exercises. His exercise price as I look at his form 4 was 50 cents on some and 70 cents on some so he was looking at a 10 banger from the time he got the options. Only a moron wouldn't cash in on that particularly when you get more options every year to replenish what you cashed in. You might learn that when you grow up and take some business classes in college, if you ever go.